Group One Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,600
| Closed | -$2.13M | – | 8432 |
|
|
2025
Q2 | $2.13M | Sell |
16,600
-17,300
| -51% | -$1.8M | ﹤0.01% | 2080 |
|
|
2025
Q1 | $3M | Sell |
33,900
-37,300
| -52% | -$3.64M | 0.01% | 1473 |
|
|
2024
Q4 | $6.21M | Sell |
71,200
-8,800
| -11% | -$806K | 0.01% | 1005 |
|
|
2024
Q3 | $7.4M | Sell |
80,000
-106,200
| -57% | -$10.5M | 0.02% | 763 |
|
|
2024
Q2 | $20.1M | Buy |
186,200
+133,700
| +255% | +$13.4M | 0.08% | 199 |
|
|
2024
Q1 | $4.98M | Buy |
52,500
+16,200
| +45% | +$1.39M | 0.02% | 829 |
|
|
2023
Q4 | $3.35M | Buy |
+36,300
| New | +$2.35M | 0.01% | 1438 |
|
|
2023
Q3 | – | Sell |
-2,900
| Closed | -$183K | – | 7661 |
|
|
2023
Q2 | $183K | Sell |
2,900
-24,900
| -90% | -$1.35M | ﹤0.01% | 4027 |
|
|
2023
Q1 | $1.25M | Buy |
+27,800
| New | +$1.25M | ﹤0.01% | 1943 |
|
|
2022
Q4 | – | Sell |
-6,100
| Closed | -$402K | – | 7258 |
|
|
2022
Q3 | $402K | Sell |
6,100
-100
| -2% | -$6.42K | ﹤0.01% | 3450 |
|
|
2022
Q2 | $313K | Buy |
6,200
+2,100
| +51% | +$123K | ﹤0.01% | 3878 |
|
|
2022
Q1 | $262K | Sell |
4,100
-9,500
| -70% | -$682K | ﹤0.01% | 4513 |
|
|
2021
Q4 | $1.46M | Buy |
+13,600
| New | +$1.42M | ﹤0.01% | 2947 |
|
|
2021
Q3 | – | Sell |
-4,400
| Closed | -$387K | – | 8181 |
|
|
2021
Q2 | $387K | Sell |
4,400
-200
| -4% | -$18.3K | ﹤0.01% | 4503 |
|
|
2021
Q1 | $447K | Sell |
4,600
-38,400
| -89% | -$3.83M | ﹤0.01% | 4178 |
|
|
2020
Q4 | $4.82M | Sell |
43,000
-40,800
| -49% | -$4.3M | 0.01% | 1304 |
|
|
2020
Q3 | $7.77M | Buy |
83,800
+15,900
| +23% | +$1.22M | 0.02% | 649 |
|
|
2020
Q2 | $5.3M | Buy |
67,900
+15,600
| +30% | +$1.06M | 0.02% | 772 |
|
|
2020
Q1 | $3.06M | Buy |
52,300
+48,700
| +1,353% | +$3.13M | 0.02% | 787 |
|
|
2019
Q4 | $288K | Sell |
3,600
-92,700
| -96% | -$6.94M | ﹤0.01% | 2895 |
|
|
2019
Q3 | $7.08M | Buy |
96,300
+55,000
| +133% | +$4.75M | 0.06% | 410 |
|
|
2019
Q2 | $3.9M | Buy |
+41,300
| New | +$3.41M | 0.04% | 672 |
|
|
2019
Q1 | – | Sell |
-6,600
| Closed | -$356K | – | 4817 |
|
|
2018
Q4 | $356K | Buy |
6,600
+2,400
| +57% | +$146K | ﹤0.01% | 2235 |
|
|
2018
Q3 | $328K | Sell |
4,200
-8,200
| -66% | -$570K | ﹤0.01% | 2630 |
|
|
2018
Q2 | $787K | Buy |
12,400
+11,300
| +1,027% | +$899K | 0.01% | 1926 |
|
|
2018
Q1 | $101K | Sell |
1,100
-5,500
| -83% | -$474K | ﹤0.01% | 3233 |
|
|
2017
Q4 | $498K | Buy |
+6,600
| New | +$464K | ﹤0.01% | 2260 |
|
|
2017
Q1 | – | Sell |
-300
| Closed | -$8K | – | 4633 |
|
|
2016
Q4 | $8K | Buy |
300
+100
| +50% | +$3.01K | ﹤0.01% | 3998 |
|
|
2016
Q3 | $6K | Buy |
+200
| New | +$4.97K | ﹤0.01% | 4170 |
|
|
2016
Q1 | – | Sell |
-5,800
| Closed | -$153K | – | 4565 |
|
|
2015
Q4 | $153K | Buy |
+5,800
| New | +$131K | ﹤0.01% | 2686 |
|
Other funds holding BPMC
IA
HNB
Group One Trading's BPMC Position: Q2 2025 in Review
Group One Trading sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 11,452 shares — an estimated $1.19M sold.
Group One Trading first reported a position in BPMC in Q1 2016 and held it in 23 quarters. The position peaked at $4.67M in Q3 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.
- Group One Trading reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 11,452 Blueprint Medicines shares in Q2 2025, an estimated $1.19M.
- Group One Trading first reported a position in Blueprint Medicines in Q1 2016 and held it in 23 quarters.
- Group One Trading's Blueprint Medicines position peaked at $4.67M in Q3 2024.
- 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.